[Infectious Diseases Society of America](https://www.idsociety.org)

July 17, 2025 (Full Proposal)

Up to $150,000 for a one-year project

Supports projects to improve identification, management, and outcomes for high-risk pediatric patients with COVID-19, focusing on early intervention and understanding disease impact.

--- ## Description This competitive grant opportunity, supported by Pfizer and administered by the Infectious Diseases Society of America (IDSA), seeks proposals for projects that enhance the ability of pediatricians, primary care providers, and pediatric infectious disease specialists to identify, assess, and manage high-risk pediatric patients affected by COVID-19. The initiative aims to improve early identification of children at risk for severe COVID-19 outcomes, emphasize timely intervention, and deepen understanding of the complications and broader impact of COVID-19 on children and healthcare systems. Priority areas include: - Improving identification of pediatric patients with high-risk conditions and their eligibility for COVID-19 treatment. - Recognizing the importance of early COVID-19 intervention/treatment in high-risk pediatric patients. - Outlining COVID-19 complications associated with high-risk conditions and their impact on pediatric patients and healthcare systems. --- ## Due Dates - Full Proposal Deadline: July 17, 2025 --- ## Funding Amount - Maximum award: $150,000 - Project duration: One year --- ## Eligibility Eligible applicants include: - Healthcare institutions - Medical, allied health, and/or pharmacy professional schools - Professional organizations/medical societies - Medical education companies Projects must be designed to support pediatricians, primary care providers, and pediatric infectious disease specialists. --- ## Application Process - Review the [Pfizer Funding Alert PDF](https://www.idsociety.org/globalassets/idsa/practice-resources/grants-and-funding/pfizer-covid-grant-funding-alerts-6.3.25---copy.pdf) for detailed requirements. - Prepare a full proposal addressing the goals and focus areas. - Submit applications as directed in the RFP and on the [Pfizer Competitive Grants Program page](https://www.pfizer.com/about/programs-policies/grants/competitive-grants). - Ensure compliance with all regulatory requirements and IDSA/Pfizer guidelines. --- ## Additional Information - The grant is part of Pfizer’s competitive grant program, which supports independent initiatives to improve patient outcomes in areas of unmet medical need. - The review process is handled internally by Pfizer. - Projects must be independent and not include promotion of Pfizer products. --- ## External Links - [Pfizer Competitive Grants Program](https://www.pfizer.com/about/programs-policies/grants/competitive-grants) - [Pfizer Funding Alert PDF](https://www.idsociety.org/globalassets/idsa/practice-resources/grants-and-funding/pfizer-covid-grant-funding-alerts-6.3.25---copy.pdf) - [IDSA Grants & Funding Opportunities](https://www.idsociety.org/practice-resources/grants-and-funding/funding-alerts) --- ## Contact Information | Contact | Details | |-------------------|------------------------------------------------------------------------| | General Inquiries | [IDSA Contact Page](https://www.idsociety.org/about-idsa/contact-us/) | | Email | [info@idsociety.org](mailto:info@idsociety.org) | | Phone | +1 703-299-0200 |

Pfizer COVID-19 Disease Burden on the Pediatric Population

Sign in to see full grant listing